Single-use Mixers Market (2026 - 2033) Size, Share & Trends Analysis Report By Product (Mixing Systems, Consumables & Accessories), By Application (Research & Development & Process Development, Commercial Manufacturing), By End Use, By Region, And Segment Forecasts

Single-use Mixers Market Summary

The global single-use mixers market size was valued at USD 1.5 billion in 2025 and is projected to grow from USD 1.6 billion in 2026 to USD 3.1 billion by 2033, at a CAGR of 9.8% from 2026 to 2033. North America held the largest share of 36.1% of the global market in 2025. The growing demand for biopharmaceuticals, the increasing concern for the environment, and the rising threat of cross-contamination are the major factors driving the growth of the single-use mixers industry.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Key Market Trends & Insights

• By product: Consumables & accessories segment held the largest market share in 2025.
• By application: Research and development (R&D) & process development segment held the largest share in 2025.
• By end use: Pharmaceutical & biotechnology companies segment held the largest market share of 42.2% in 2025.

Regional Highlights

• Largest regional market: North America (36.1% revenue share, 2025)
• By country: The U.S. single-use mixers industry is expected to grow significantly over the forecast period.

Market Size & Forecast

• Market size in 2025: USD 1.5 Billion
• Estimated market size in 2026: USD 1.6 Billion
• Projected market size by 2033: USD 3.1 Billion
• CAGR (2026-2033): 9.8%

To learn more about this report, Download Free Sample Report

Flexibility & Scalability

A key driver of the single-use mixers industry is the flexibility and scalability offered to biopharma manufacturers, which is difficult to achieve with traditional stainless-steel systems that require infrastructure and time to set up. Single-use mixers allow companies to adjust their production capacity based on project needs easily. This is particularly advantageous during the early stages of research, clinical trials, and large-scale commercial manufacturing, as it enables an easy transition from small-batch to large-scale production without significant capital expenditures.

The ability to scale up or down quickly is crucial in today’s dynamic biopharma landscape, where demand for biologics, vaccines, and cell-based therapies can fluctuate rapidly.

Key Technological Advancements in the Single-Use Mixers Market 

Source: Secondary Research, Grand View Research

Moreover, single-use mixers are critical at multiproduct manufacturing sites where biologics or therapies are produced in the same facility. Traditionally, when products were changed, there were lengthy downtimes to address extensive cleaning, validation, and testing. Internally, this led to inefficiencies, increased the risk of cross-contamination, and delayed the new product's time-to-market. Single-use systems remove bottlenecks, enabling seamless transitions, faster changeovers, and reduced downtime. This enables even greater productivity and responsiveness to market needs. As companies increasingly focus on personalized medicines and high-value biologics that require more flexible production processes, the need for adaptable, scalable approaches such as single-use mixers is growing.

Reduced Risk of Contamination

The decreased risk of contamination in biopharmaceutical manufacturing is driving the adoption of single-use mixers. Traditional stainless-steel systems require cleaning and sterilization between batches to prevent contamination, but this process is time-consuming and risky if cleaning validation is not properly conducted. In single-use mixers, the need for all this cleaning is eliminated because the system is used only once. Each new production run will begin with a sterile, contamination-free system. Therefore, there will be minimal risk of product failure, recalls, or regulatory and compliance issues. The safety that this approach can provide is important for all manufacturers, especially those developing high-value biologics.

Moreover, global regulatory bodies, including the U.S. FDA and EMA, have implemented strict good manufacturing practice requirements to ensure the safety and quality of drugs. As biologics and cell- and gene-based therapies continue to dominate pipelines, the assurance of contamination-free production provided by single-use mixers has become a strategic enabler for companies seeking compliance and consistent product quality.

Market Concentration & Characteristics

The degree of innovation in the single-use mixers industry is high, driven by continuous advancements in bioprocessing technologies and the increasing demand for flexible manufacturing solutions. Innovations such as integrated closed-system solutions, modular platforms, and interoperability with continuous bioprocessing improve process reliability and regulatory compliance. Moreover, trends toward sustainable design, including the use of recyclable materials and reduced plastic use, will shape the future of product design. For instance, in April 2025, Thermo Fisher Scientific introduced its 5L DynaDrive single-use bioreactor in the U.S., providing a first-of-its-kind bench-scale system that simplifies process development and enables seamless scalability. These innovations differentiate market players and accelerate the adoption of single-use mixers across biopharma, vaccines, and cell and gene therapy manufacturing.

The level of M&A activity in the single-use mixers industry is moderate to high, reflecting the growing strategic importance of single-use technologies within the broader bioprocessing ecosystem. Leading biopharma suppliers and technology providers are actively pursuing acquisitions to strengthen their portfolios, expand global reach, and integrate complementary technologies such as sensors, automation tools, and downstream processing solutions. For instance, in August 2025, Tezalon Biotech partnered with Ireland-based Strikebox to advance scalable bioprocess solutions, combining modular single-use systems with precision fabrication to accelerate therapy development in the U.S. and Europe. These consolidations allow companies to offer end-to-end bioprocessing solutions and intensify competition by creating vertically integrated giants with strong customer bases.

To learn more about this report, Download Free Sample Report

Regulations have a significant impact on the single-use mixer industry, as compliance with stringent quality and safety standards is critical in biopharmaceutical manufacturing. Regulatory agencies like the U.S. FDA, EMA, and other global bodies impose strict requirements for Good Manufacturing Practice (GMP), including sterility, validation, and traceability for equipment and processes. This creates a regulatory framework that drives and shapes the market by requiring companies to adopt innovative single-use solutions that meet globally accepted quality standards.

Product innovation is an important driver in the single-use mixers industry as manufacturers are actively introducing new products to meet the changing needs of biopharmaceutical production methods. Manufacturers are introducing mixers that deliver better mixing performance, are available in larger or more flexible volumes, and can be used with a broader range of biologics, cell cultures, and buffers. This ongoing diversification of products is aimed at specific customer needs while enabling suppliers to gain a competitive advantage, thereby increasing the adoption of single-use technologies across vaccine, biologic, and cell and gene therapy processes.

Regional expansion is becoming a major growth driver in the single-use mixers industry as manufacturers move to capitalize on opportunities in emerging biopharmaceutical hubs worldwide. Suppliers are opening local sales offices and distribution networks, setting up service centers to capitalize on those opportunities, and entering into partnerships with regional contract development and manufacturing organizations (CDMOs). The development of these regions enables manufacturers to increase market penetration and local presence, providing quicker support, stronger customer relationships, and customized solutions that address unique regulatory and operational requirements.

Product Insights

The consumables & accessories segment dominated the market with a 58.9% market share in 2025 and is also expected to grow fastest throughout the forecast period, driven by growing demand for mixing fluids, such as buffers and culture media, and processes for various research purposes and vaccine development. Many consumables and some accessories, such as mixing bags, can even be customized based on the client's demands, enabling low cost and reducing the risk of contamination for a cleaner environment.

Mixing systems are expected to grow significantly throughout the forecast period, as they are useful tools for R&D applications in the biopharmaceutical industry. Factors such as flexibility, scalability, cost-effectiveness, and reduced contamination risk make them appealing to R&D centers. Combining mixing with removal, cleaning, and sterilization will reduce the time and resources required to prepare and run an experiment.

Application Insights

The research and development (R&D) & process development segment dominated the industry with a 64.5% market share in 2025, driven by the tractability, scalability, cost-effectiveness, and reproducibility these systems offer. Single-use mixers are particularly well-suited for vaccine development, where small variations in experimental conditions can significantly impact the final product. Thus, R&D & process development centers are increasingly turning to single-use technology to conduct experiments more quickly and with greater precision, driving the industry's research and development (R&D) & process development segment forward.

Commercial manufacturing is anticipated to grow with the fastest CAGR during the forecast period. These mixers generate less waste than traditional mixing methods, thereby reducing the environmental impact of commercial manufacturing processes. Biopharma companies have slowly started using single-use mixers for commercial manufacturing, that is, large-scale biologics production, focusing on efficient and consistent output, supporting market expansion.

End Use Insights

The pharmaceutical and biotechnology companies segment dominated the market with a 42.2% market share in 2025, driven by the major commercial success of biologics. Benefits such as cost-effectiveness, compliance, flexibility, and the adoption of innovative techniques offer pharmaceutical and biotechnology companies opportunities to improve their manufacturing processes. Thus, the rising demand for more efficient production of vaccines and other biologics at lower cost is anticipated to strengthen the industry over the forecast period.

To learn more about this report, Download Free Sample Report

The CMOs & CROs segment is expected to grow fastest during the forecast period. Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs) maintain competitiveness by producing biologics more effectively and affordably, especially for R&D and clinical trials. For instance, according to an article published by SIAPARTNERS in April 2022, approximately 60% of companies reported savings of 10% to 25% through outsourcing, while the remaining 40% reported savings of up to 40%. Using single-use technologies offers many benefits for CMOs and CROs, including greater flexibility, faster turnaround times, and reduced capital expenditures, thereby increasing the adoption of single-use mixers.

Regional Insights

North America single-use mixers industry dominated the global market, with the largest revenue share of 36.1% in 2025. This region's large share is attributed to increased adoption of novel technologies and biopharmaceuticals for the analysis and treatment of clinical ailments. Moreover, the supporting regulatory environment, increased investments in R&D, and new clinical studies for innovative therapies continue to bolster single-use mixer adoption in North America and sustain its position as the largest market worldwide.

To learn more about this report, Download Free Sample Report

U.S. Single-Use Mixers Market Trends

The U.S. single-use mixers industry is highly competitive, fueled by the strong presence of global bioprocessing leaders, rapid adoption of advanced manufacturing technologies, and the increasing demand for biologics and personalized medicines. Continuous innovation in single-use systems, including integration with automation, sensors, and real-time monitoring tools, has further intensified competition among suppliers.

Europe Single-use Mixers Market Trends

The Europe single-use mixers industry is experiencing steady growth due to an established biopharmaceutical manufacturing sector, increasing investments in advanced therapies, and the implementation of flexible manufacturing technologies. While the ongoing demand for monoclonal antibodies, vaccines, and cell and gene therapies leads biopharma companies to adopt single-use systems, this demand also benefits from improvements in scalability, production efficiency, and compliance with EU regulations.

The UK single-use mixers industry is expanding, supported by the country’s strong biopharmaceutical and life sciences ecosystem and increasing investments in advanced manufacturing technologies. Moreover, the UK has specialized contract manufacturing and research organizations that offer access to single-use technologies, making them a key part of the country's evolving bioprocessing landscape.

The Germany single-use mixers industry is growing because of supportive government initiatives to strengthen domestic biotech production. Moreover, Germany’s emphasis on regulatory compliance, process standardization, and sustainable manufacturing practices aligns well with the benefits of single-use mixers, reinforcing their growing role in the country’s bioprocessing ecosystem.

Asia Pacific Single-use Mixers Market Trends

Asia Pacific single-use mixers industry is anticipated to grow at the fastest CAGR of 14.6% during the forecast period. The significant progress in the pharmaceutical and biotechnology industries in the region is a major driver of single-use technology development. Countries such as China, India, and Japan are estimated to witness high growth due to growing government investment in R&D centers, thus influencing the significant use of SUM in vaccine production and other research.

The China single-use mixers industry is growing rapidly, due to the push by the country to upgrade its biomanufacturing infrastructure and decrease dependence on imported systems. Unlike in more mature markets, China's growth largely depends on the government's "Made in China 2025" strategy, which emphasizes local production of biologics and advanced therapies. Domestic biotech firms and startups are increasingly integrating single-use mixers to shorten facility build times and reduce upfront capital expenditures, which are crucial in a cost-sensitive yet fast-expanding market. International suppliers are also forming joint ventures or partnerships with Chinese companies to bring in advanced technology while integrating local cost and regulatory considerations, thereby accelerating adoption.

The Japan single-use mixers industry is growing, supported by the country’s strong focus on precision medicine, regenerative therapies, and advanced biologics. Japan's healthcare system is notable for early adoption of new treatments, such as stem cell and gene therapies, which require smaller, flexible, and contamination-free production systems, making single-use mixers attractive. The country’s emphasis on high-quality standards and efficient facility utilization positions single-use mixers as a critical enabler in advancing its biopharma and regenerative medicine sectors.

MEA Single-use Mixers Market Trends

The Middle East and Africa (MEA) single-use mixers industry is emerging, driven by rising investments in healthcare infrastructure, growing interest in local biopharmaceutical manufacturing, and an increasing focus on vaccine and biologics production. Countries in the region, such as the UAE, Saudi Arabia, and South Africa, have made biotechnology part of their national healthcare and economic diversification plans, creating new opportunities to adopt flexible single-use technologies. As awareness and investment grow, MEA is increasingly positioned as a frontier market for single-use mixers, particularly in contract manufacturing and vaccine development.

The Kuwait single-use mixers industry is developing but steadily growing, driven by the country’s initiatives to expand its biotechnology and healthcare manufacturing capabilities. With increasing government investment in advanced healthcare infrastructure and a focus on local production of vaccines and biologics, Kuwait is gradually adopting flexible, scalable, and contamination-free single-use technologies such as single-user mixers.

Key Single-use Mixers Company Insights

The single-use mixers industry is characterized by several established players who maintain dominance through comprehensive product portfolios, technological innovation, and strategic partnerships. Top players in the industry, such as Sartorius AG, Danaher, Merck KGaA, and Thermo Fisher Scientific, Inc., have gained significant market share due to their superior single-use technologies, strong process automation capabilities, and extensive global distribution networks. These firms continue to set industry standards by offering scalable, contamination-free mixing systems for biopharmaceutical, vaccine, and cell and gene therapy manufacturing.

Organizations including Meissner Filtration Products, DrM, Dr. Mueller AG, VWR International, CerCell A/S, AGILITECH, and Holloway America, LLC are broadening their reach by delivering specialized and customizable single-use solutions. Their products meet the increasing demand for flexible, modular, high-performance mixers that optimize operations, minimize risk of cross-contamination, and speed time-to-market of critical biologics and advanced therapies.

The combination of technological innovation and applied engineering expertise increasingly impacts the competitive environment. Strategic partnerships, mergers and acquisitions, and ongoing R&D investment drive greater mixing performance, enhanced sterilization assurance, and real-time monitoring of mixing. The factors most likely to shape the single-use mixers industry moving forward are accessibility, efficient manufacturing processes, large-scale inputs, and regulatory compliance, as they align with overarching trends in flexible biomanufacturing and sustainable production. 

Recent Developments

• In September 2025, FlackTek launched the MEGA FlackTek in the U.S., the world’s largest high-speed bladeless planetary mixer, enabling high-throughput, precision mixing from R&D to full-scale production.

• In May 2025, Avantor launched its magnetic mixing systems in the U.S., offering scalable single-use mixers from 10 L to 1,500 L for homogeneous, low-shear biologics processing.

• In January 2025, MDI launched universal single-use mix bags compatible with major mixing platforms, addressing supply constraints and high costs. The scalable system incorporated validated Aseptiflex film, demonstrated effective mixing performance, and offered economic advantages, along with improved supply security through dual sourcing

Global Single-use Mixers Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global single-use mixers market report based on product, application, end use, and region:

To learn more about this report, Download Free Sample Report

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Mixing Systems

  • Consumables & Accessories

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Research and Development (R&D) & Process Development

  • Commercial Manufacturing

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Pharmaceutical & Biotechnology Companies

  • CMOs & CROs

  • Academic & Research Institutes

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe​​​​​​​

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific​​​​​​​

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America​​​​​​​

    • Brazil

    • Argentina

  • Middle East & Africa​​​​​​​

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait